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Abstract
Background: Dengue virus (DENV) is the most widespread arbovirus with an estimated 100 million infections occurring
every year. Endemic in the tropical and subtropical areas of the world, dengue fever/dengue hemorrhagic fever (DF/DHF) is
emerging as a major public health concern. The complex array of concurrent host physiologic changes has hampered a
complete understanding of underlying molecular mechanisms of dengue pathogenesis.
Methodology/Principle Findings: Systems level characterization of serum metabolome and lipidome of adult DF patients at
early febrile, defervescence, and convalescent stages of DENV infection was performed using liquid chromatography- and
gas chromatography-mass spectrometry. The tractability of following metabolite and lipid changes in a relatively large
sample size (n= 44) across three prominent infection stages allowed the identification of critical physiologic changes that
coincided with the different stages. Sixty differential metabolites were identified in our metabolomics analysis and the main
metabolite classes were free fatty acids, acylcarnitines, phospholipids, and amino acids. Major perturbed metabolic
pathways included fatty acid biosynthesis and b-oxidation, phospholipid catabolism, steroid hormone pathway, etc.,
suggesting the multifactorial nature of human host responses. Analysis of phospholipids and sphingolipids verified the
temporal trends and revealed association with lymphocytes and platelets numbers. These metabolites were significantly
perturbed during the early stages, and normalized to control levels at convalescent stage, suggesting their potential utility
as prognostic markers.
Conclusions/Significance: DENV infection causes temporally distinct serum metabolome and lipidome changes, and many
of the differential metabolites are involved in acute inflammatory responses. Our global analyses revealed early anti-
inflammatory responses working in concert to modulate early pro-inflammatory processes, thus preventing the host from
development of pathologies by excessive or prolonged inflammation. This study is the first example of how an omic-
approach can divulge the extensive, concurrent, and dynamic host responses elicited by DENV and offers plausible
physiological insights to why DF is self limiting.
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Introduction
Dengue virus (DENV) is a member of the Flavivirus genus of
the Flaviviridae family and is classified into four distinct serotypes.
It is estimated that 100 million dengue infections occur worldwide
every year, ranging from acute dengue fever (DF) to life-
threatening dengue haemorrhagic fever/dengue shock syndrome
(DHF/DSS) [1,2]. Dengue is emerging as a global health concern
with the annual average number of DF/DHF cases reported
to World Health Organization increasing dramatically in
recent years. Furthermore, DENV has spread widely, and all
four serotypes are now circulating in Asia, Africa and the
Americas [3].
DF is generally self-limiting, but its symptoms can be
debilitating and cause considerable incapacitating morbidity,
which have a significant health and economic toll in the society.
In a small percentage of patients, DF evolves to the more severe
forms of DHF and DSS, which are characterized by abnormal
hemostasis, vascular leakage and liver damage. There is currently
no specific antiviral therapy or vaccine available for DF or DHF/
DSS. Furthermore, the underlying molecular mechanisms of
DENV pathogenesis are still unclear and why DF resolves in time
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is largely neglected. Therefore, the pathological differences
between the severe DHF/DSS and the mild, self-limiting, DF
suggest differential virus-host interactions in the susceptibility to
the disease. Both viral and host immune factors seem to be
involved, but the role of each is not fully understood [4].
Meanwhile, the lack of an appropriate animal model significantly
increases the challenges in the study of DENV pathogenesis.
Metabolomics and lipidomics are rapidly emerging fields of
‘omics’ research that aim to study the global changes of small
molecule metabolites and lipids in biological systems in response to
biological stimuli or perturbations [5]. Metabolites are the end
products of cellular regulatory processes, forming a link between
molecular changes and phenotype, and therefore reflect the
physiological state of a cell, tissue or organism at a point in time.
Lipidomics covers the subset of lipid constituents, which are
known to be involved in signalling and infection biology. Cellular
homeostasis is interrupted under disease conditions, and the
human body would attempt to maintain a basal, internal
environment by increasing or decreasing levels of certain
endogenous metabolites. Thus, by providing a snapshot of the
metabolic status of an organism, metabolomics holds the promise
of finding metabolic pathways related to disease processes [6,7].
Metabolomics has been applied to infectious diseases to study host-
pathogen interactions [8,9,10]. Similarly, there has been enor-
mous interest in how lipids and their metabolism influence
Flaviviridae viral infection, especially from the perspective of
microbe lipid usage for virus entry, replication and release
[11,12,13]. As we redefine the manner in which we understand
the complex and dynamic virus-host interactions of dengue
infection in vivo, it necessitates capturing the global changes rather
than isolated ones. However, few omics studies exist that describe
how the human host response biochemically and physiologically
during DENV and other flavivirus infection and how it resolves
without intervention [14,15]. Therefore we turned our attention to
examine serum metabolites and lipids using a comprehensive
approach to globally capture the human responses to DF.
In our previous study, a systematic characterization of serum
cytokines, proteome, and markers of macrophage and neutrophil
activity was reported from a subset of longitudinally enrolled adult
patients with primary dengue infections [16]. In the present study,
both untargeted metabolomics and targeted lipidomics on the
same serum sample set were conducted with the aim to identify
metabolic pathways linked to disease progression and understand
the mechanisms of DENV infection. Our results showed that
DENV infection caused significant serum metabolome and
lipidome-wide changes in DF patients. Sixty differential metabo-
lites were identified in metabolomics analysis and detailed
examination of metabolic pathways changes revealed that in
primary DENV infections, acute inflammatory responses were
quickly met with active pro-resolution counterbalances to restore
homeostasis. Our studies also implicated the plausible association
of sphingomyelins with CD8+ lymphocyte activation during the
early febrile period, and plasmalogen phosphatidylethanolamines
and lysophosphatidylethanolamines with platelet numbers during
the later phases of defervescence and convalescence. We propose
that early widespread host changes in the metabolome and
lipidome play an important physiological component in defining
the self-limiting outcome of DF.
Materials and Methods
Ethics statement
The early dengue infection and outcome (EDEN) study is a
multi-center longitudinal study, which prospectively recruits and
follows-up adult dengue patients in Singapore, through early
febrile, defervescence as well as convalescence stages of the disease
[17]. Enrolment of all eligible individuals was based on written
informed consent and the protocols were approved by the
National Healthcare group (DSRB B/05/013). All samples were
anonymized.
Clinical samples
The details of patient recruitment, sample collection and the
study protocols of EDED study have been described earlier [18].
In brief, adult patients (.21 years) presenting with acute onset
fever ($38.0uC for less than 72 hours) without rhinitis or other
clinical alternatives were included in the study (Visit 1; febrile).
Initial dengue diagnosis was made by real time RT-PCR and
followed by serology and subsequent serotyping by virus isolation
and immunofluorescence using serotype specific monoclonal
antibodies (ATCC: HB46-49). Venous blood samples were also
collected at fever day 4 to 7 (Visit 2; defervescence) and weeks 3 to
4 (Visit 3; convalescence), aliquoted and frozen at 280uC. ‘Fever
day’ here refers to number of days post onset of fever.
Classification of DF was made based on the guidelines provided
by the World Health Organisation [19]. In brief, acute febrile
patients positive for dengue with one or more of the following
symptoms: headache, retro orbital pain, myalgia, rash, leucopenia,
hemorrhage were classified as DF. Of the 133 dengue patients that
were finally enrolled in this study (September 2005–October
2006), 44 DF patients tested negative for dengue IgG antibodies in
the acute sera, using a commercially obtained ELISA (PanBio,
Brisbane, Australia). These patients were deemed to have primary
DENV infection, all of which were included in this study. A
detailed hematological and virological analysis was also per-
formed. Additionally we used serum samples from 50 asymptom-
atic age-matched healthy subjects participated during a hospital
staff annual examination as controls (Table 1). This study was
Author Summary
Dengue virus is the most widespread arbovirus and a
major public health threat in the tropical and subtropical
areas of the world. As yet, little is known about the
molecular mechanisms underlying infection, and there is
no specific treatment or vaccine that is currently effective
against the disease. Metabolomics and lipidomics provide
global views of metabolome and lipidome landscapes and
implicate metabolic to disease phenotype. We performed
serum metabolic and lipidomic profiling on a cohort of
dengue patients with three sampling time points at early
febrile, defervescence, and convalescent stages via mass
spectrometry-based analytical platforms. Compared with
healthy subjects, approximately two hundred metabolites
showed significant difference in dengue patients, and 60
were identified. This study revealed that in primary dengue
infection, the host metabolome is tightly regulated, with
active, early anti-inflammatory processes modulating the
pro-inflammatory processes, suggesting the self-limiting
phenotype of dengue fever. Major perturbed metabolic
pathways included fatty acid biosynthesis, fatty acid b-
oxidation, phospholipid catabolism, steroid hormone
pathway, etc. This represents a first report on the
characterization of the serum metabolome and signifi-
cantly advances our understanding on host and dengue
virus interactions. These differential metabolites have the
potential as biomarkers for disease monitoring and
evaluation of therapeutic interventions.
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approved by the National University of Singapore Institutional
Review Board and samples were collected with individual
informed written consents.
Serum sample preparation
For metabolomics analysis, a volume of 50 mL from each serum
sample was thawed at 4uC. Serum proteins were precipitated with
200 mL ice-cold methanol, which contained 10 mg/mL 9-fluor-
enylmethoxycarbonyl-glycine as an internal standard. After
vortexing, the mixture was centrifuged at 16,000 rpm for
10 minutes at 4uC and the supernatant was divided into two
parts, one for liquid chromatography/mass spectrometry (LC-MS)
analysis and the other for gas chromatography/mass spectrometry
(GC-MS) analysis. All samples were kept at 4uC and analyzed
within 48 h. In order to prevent batch effect, the assays were
conducted in random manner. Quality control (QC) samples were
prepared by mixing equal amounts of serum samples from 10
healthy subjects and 10 DF patients at all the three time points.
For lipidomics analysis, due to limited sample availability, sera
from three patients at each visit were randomly pooled (14 pools
total). Lipids were extracted from serum using a modified Bligh
and Dyer method [20]. Briefly, 900 mL of chloroform-methanol,
1:2 (v/v) was added to 100 mL serum. After 20 min vortexing and
incubation at 4uC, 300 mL of chloroform and 300 mL of ddH2O
were added to the mixture and centrifuged at 9000 rpm, 4uC for
2 min. Lipids were then recovered from the lower organic phase
after centrifugation. Subsequently, 500 mL of chloroform was
added, vortexed at 4uC for 20 min. After centrifugation, lipids
were recovered from the organic phase and combined with the
previous fraction. The lipid extracts were vacuum-dried, stored at
280uC and analyzed within a week.
Metabolomics analysis by LC-MS
The supernatant fraction from sample preparation step was
analyzed using Agilent 1290 ultrahigh pressure liquid chromatog-
raphy system (Waldbronn, Germany) equipped with a 6520 Q-
TOF mass detector managed by a MassHunter workstation. The
column used for the separation was an Agilent rapid resolution
HT Zorbax SB-C18 (2.1650 mm, 1.8 mm; Agilent Technologies,
Santa Clara, CA, USA). The oven temperature was set at 50uC.
The gradient elution involved a mobile phase consisting of (A)
0.1% formic acid in water and (B) 0.1% formic acid in methanol.
The initial condition was set at 5% B. A 7 min linear gradient to
70% B was applied, followed by a 12 min gradient to 100% B
which was held for 3 min, then returned to starting conditions
over 0.1 min. Flow rate was set at 0.4 ml/min, and 5 mL of
samples was injected. The electrospray ionization mass spectra
were acquired in both positive and negative ion mode. Mass data
were collected between m/z 100 and 1000 at a rate of two scans
per second. The ion spray voltage was set at 4,000 V, and the
heated capillary temperature was maintained at 350uC. The
drying gas and nebulizer nitrogen gas flow rates were 12.0 L/min
and 50 psi, respectively. Two reference masses were continuously
infused to the system to allow constant mass correction during the
run: m/z 121.0509 (C5H4N4) and m/z 922.0098
(C18H18O6N3P3F24). The stability of the LC-MS method was
examined and evaluated by a subset of peaks covering a range of
masses, intensities, and retention times across the QC samples
(Table S1). Variations of retention time and m/z values of the
peaks were less than 0.2 min and 10 mDa, respectively, and the
relative standard deviations of peak areas were below 20%,
indicating good reproducibility and stability of the chromato-
graphic separation and mass accuracy of mass measurement
during the whole sequence.
Metabolomics analysis by GC-MS
100 mL supernatant fraction from sample preparation step was
dried under nitrogen and derivatised with 150 mL methoxamine
(50 mg/mL in pyridine, 37uC62 h) followed by 150 mL N-methyl-
trimethylsilyl-trifluoroacetamide (37uC616 h). After centrifuga-
tion (4uC, 6000 rpm61 min), the supernatant fraction was
injected into GC-MS. The derivatised sample (1.0 mL) was
introduced by splitless injection with an Agilent 7683 Series
autosampler into an Agilent 6890 GC system equipped with a
fused-silica capillary column HP-5MSI (30 m60.25 mm i.d.,
0.25 mm film thickness) as reported previously [21]. The inlet
temperature was set at 250uC. Helium was used as the carrier gas
at a constant flow rate of 1.0 ml/min. The column effluent was
introduced into the ion source of an Agilent Mass selective
detector. The transfer line temperature was set at 280uC and the
ion source temperature at 230uC. The mass spectrometer was
operated in electron impact mode (70 eV). Data acquisition was
performed in full scan mode from m/z 50 to 550 with a scan time
of 0.5 sec. The compounds were identified by comparison of mass
spectra and retention time with those of reference standards, and
those available in libraries (NIST 0.5). A summary of the workflow
utilized in metabolomics study is shown in Figure S1.
Lipidomics analysis by LC-MS/MS
To facilitate interrogation of the serum lipidome in a high-
throughput, targeted and accurate fashion, we employed LC-MS/
MS in Multiple Reaction Monitoring (MRM) mode to survey
more than 200 individual glycerophospholipids and sphingolipids
simultaneously at linear dynamic ranges of 0.1 to 100 ng/mL.
Prior to ESI-LC-MS/MS, each lipid extract was reconstituted in
400 mL of chloroform-methanol (1:1 v/v). LC-MS/MS via Triple
Quadrupole 6460 with Jet StreamTM (Agilent Technologies) was
used for the quantification of glycerophospholipids and sphingo-
lipids (total .200 molecular species). C-18 reversed phase LC
(Zorbax Eclipse 2.1650 mm I.D., 1.8 mm; Agilent Technologies)
was used to separate 5 mL reconstituted lipids at 400 mL/min
before entering the mass spectrometer. The column thermostat
and autosampler temperatures were maintained at 40uC and 6uC,
respectively. The optimized mobile phase consisted of 5 mM
ammonium acetate in water (solvent A) and 5 mM ammonium
acetate in methanol (solvent B). The gradient of the samples was:
0–2 min, 60–100% B; 2–7 min, maintained at 100% B; 7–9 min,
100–60% B and 9–11 min, 60% for column re-equilibration
before the next injection. Positive ionization mode [M+H]+ MRM
Table 1. Demographics of healthy subjects and dengue
patients enrolled in this study.
Patient
Groups Serotype Age Gender
Blood sampling
time*
DF (n= 44) D1 (54.5%) 39.0613.0 27 (male) 46620 hours (Visit 1)
D2 (2.3%) 17 (female) 73631 hours (Visit 2)
D3 (43.2%) 1665 days (Visit 3)
D4 (0)
Controls
(n= 50)
NA 40.0618.0 14 (male) NA
36 (female)
*Average time from fever to phlebotomy (Visit 1), between Visits 1 & 2 (Visit 2)
and between Visits 2 & 3 (Visit-3).
doi:10.1371/journal.pntd.0002373.t001
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was based on product ion m/z 264.4 [sphingosine-H2O]
+ and
266.4 [sphinganine-H2O]
+ for ceramide (Cer), monohexosylcer-
amide (MHexCer), lactosylceramide (LacCer) and ceramide-1-
phosphate (C1P), and m/z 184.1 [phosphocholine]+ for sphingo-
myelin (SM). Negative ionization [M-H]2 MRM mode based on
specific parent and product ion pairs was employed for
phosphatidic acid (PA), phosphatidylinositol (PI), lysophosphati-
dylinositol, phosphatidylethanolamine (PE), lysophosphatidyletha-
nolamine (lysoPE), plasmalogen phosphatidylethanolamine (pPE),
phosphatidylglycerol (PG), phosphatidylserine (PS) and lysopho-
sphatidylserine (lysoPS) for identification and quantification of the
above glycerophospholipids [22]. The optimized lipid-class
dependent mass spectrometry parameters are shown in Table
S2. Known concentrations (20–100 ng/mL) of non-naturally
occurring internal standards, namely Cer d18:1/17:0, GlcCer
d18:1/8:0, LacCer d18:1/8:0, SM d18:1/12:0, C1P d18:1/17:0,
PA 14:0, PC 14:0, PE 14:0, PG 14:0, PS 14:0 and PI 14:0; Avanti
Polar Lipids, Alabaster, Al) were verified of their low abundance in
sera, spiked into extracted samples and used in absolute
quantification. The linear dynamic ranges, limits of detection,
limits of quantification and relative standard deviation of the
various lipids are shown in Table S3. The effect of acyl length on
signal intensity [23,24] was compensated by adjusting the collision
energy and fragmentor voltage (Table S2). A summary of the
workflow utilized in the lipidomics study is shown in Figure S2.
Data analysis
For metabolomics analysis, raw spectrometric data were
converted to mzData (LC-MS/MS) and NetCDF (GC-MS)
formats via Masshunter (Agilent, US) and input to open-source
software MZmine 2.0 for peak finding, peak alignment and peak
normalization across all samples [25]. The MZmine 2.0 report
table was exported into SIMCA-P software (version 11.0; Umetrics
AB, Umea, Sweden) for multivariate data analysis. Data sets were
mean-centered and pareto-scaled to adjust the importance of high
and low abundance metabolites to an equal level before carrying
out statistical analyses. Unsupervised multivariate analysis princi-
ple component analysis (PCA) was first performed on LC-MS data
as an unbiased statistical method to observe intrinsic trends within
healthy controls and DF patients at different visits. To achieve the
maximum separation among the groups, supervised multivariate
analysis orthogonal partial least-squares discriminant analysis
(OPLS-DA) was sequentially applied. Potential differential metab-
olites were selected according to the Variable Importance in the
Projection (VIP) values and the variables with VIP.1 were
considered to be influential for the separation of samples in OPLS-
DA analysis. In addition, the Kruskal-Wallis test was performed to
determine if the differential metabolites obtained from OPLS-DA
modelling were statistically significant (p,0.05) among groups at
the univariate analysis level.
For lipidomics analysis, undetectable lipids were replaced with
1/10 of the lowest non-zero value measured. In cases where 70%
of data are missing from patients, lipids were excluded. Missing
data represents 1.8% of the data. In total 207 lipids remained for
further analysis. Comparisons between groups were achieved using
non-parametric analysis namely two-tailed Mann-Whitney tests
and Kruskal-Wallis tests with Dunn’s post hoc analysis. Repeated
one-way ANOVA was used for paired analysis with the Bonferroni
Multiple Comparison post hoc Test.
Compound identification and pathways analysis
The structure identification of the differential metabolites was
based on a previously described strategy [26]. The identification
process is illustrated here with hexanoylcarnitine, one of the ten
differential acylcarnitines. First, the element composition
C13H25NO4 of the m/z 260.18 ion was calculated based on the
exact mass, the nitrogen rule and the isotope pattern by
Masshunter software from Agilent (Figure S3A). Then, the
elemental composition and exact mass were used for open source
database searching, including LIPIDMAPS (http://www.
lipidmaps.org/), HMDB (http://www.hmdb.ca/), METLIN
(http://metlin.scripps.edu/) and MassBank (http://www.
massbank.jp/). Next, MS/MS experiments were performed to
obtain structural information via the interpretation of the
fragmentation pattern of the metabolite (Figure S3B). In the
case of acylcarnitines, m/z 85.0 is the characteristic fragment ion
in the MS/MS spectrum [27]. The MS/MS spectra of possible
metabolite candidates in the databases were also searched and
compared. As a result, the metabolite was identified as
hexanoylcarnitine, which was finally confirmed by comparison
with the standard (Figure S3C). Both MetaboAnalyst [28] and
Ingenuity Pathway Analysis software (IPA, www.ingenuity.com)
were used to identify relevant pathways.
Results
Global metabolome changes with dengue fever
In order to obtain a high level snapshot of metabolite flux at the
different stages of dengue infection represented in our clinical
samples, we examined variances in our data both by principal
component analysis (PCA) as well as OPLS-DA. The PCA score
plot (Figure 1A) indicates that the metabolome changes in DF
patients are reversible. The most predominant metabolome
changes in DF patients, as compared with healthy controls,
happened at early febrile stage (Visit 1), followed by the
defervescence stage (Visit 2) and finally returned to the control
levels at the convalescence stage (Visit 3). This indicates that the
most intense responses of the DF patients to DENV infection
happen within the first 72 hours upon infection, and homeostatic
recovery appears to begin around the fourth day from the onset of
fever. This, more or less, coincides with the course of viraemia,
which has been observed to peak during early febrile phase and
are generally undetectable during the defervescence stage. The
duration of DF illness in the EDEN study is reported to be 7–14
days [18], and a majority of patients recover within three to four
weeks as seen at Visit 3, which could explain the metabolome
similarities between patients at Visit 3 and healthy controls in the
PCA score plot. In addition, PCA did not reveal distinct
metabolome profiles between DENV serotype 1 and DENV
serotype 3. This suggests converging host responses between the
two serotypes which resulted in DF. While host molecular changes
may be present between infections with different DENV serotypes,
a larger patient set will be required to tease out the significant
subtle differences.
OPLS-DA, which is a more rigorous classification tool, revealed
clearer segregation of the healthy controls and DF patients during
the three visits (Figure 1B). The quality of the OPLS-DA model
was evaluated by R2 (Y) and Q2 parameters, which indicated the
fitness and prediction ability, respectively. By using four principle
components, the OPLS-DA model showed a R2 value of 0.95 and
Q2 value of 0.91, indicative of optimal performance of the model.
The OPLS-DA was also applied to GC-MS data, which showed a
R2 value of 0.65 and Q2 value of 0.60.
Identification of significantly altered metabolites and
pathways
Approximately 200 differential metabolites identified via both
LC-MS/MS and GC-MS analyses were selected based on the
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PLOS Neglected Tropical Diseases | www.plosntds.org 4 August 2013 | Volume 7 | Issue 8 | e2373
Metabolomics and Lipidomics of Dengue Fever
PLOS Neglected Tropical Diseases | www.plosntds.org 5 August 2013 | Volume 7 | Issue 8 | e2373
criteria- VIP.1 in OPLS-DA analysis and p,0.05 in Kruskal-
Wallis test (Table S4, S5). Sixty of these metabolites were
structurally identified, with 56 through LC-MS/MS analysis, and
8 by GC-MS analysis, 4 of which were common to both these
methods. These metabolites belonged to classes such as free fatty
acid, acylcarnitine, phosphatidylcholine (PC), lysophosphatidyl-
choline (LysoPC), LysoPE, amino acid and derivative, sphingolip-
id, monoacylglyceride (MG), diacylglyceride (DG), purine, bile
acid, bile pigment, steroid hormone, glucose and phenol sulfate
(Table S4). Consistent with the PCA score plot (Figure 1A), the
quantitative heatmap (Figure 2) of these differential metabolites
revealed that the metabolome changes were reversible in DF
patients. They were significantly perturbed during the early stages,
and normalized to control levels at convalescent stage.
These differential metabolites show two contrasting time-course
changes, an elevated and a decreased trend, at Visit 1 and Visit 2.
Most of the metabolites have either the highest or the lowest levels
at Visit 1, which is the acute stage of DENV infection, and
gradually return to the control levels at Visit 3, indicating that they
might serve as prognostic markers of the disease.
It is interesting that the metabolites within each metabolite class
generally showed a similar change trend. Specifically, seven FFAs,
including four polyunsaturated fatty acids (PUFAs): arachidonic
acid (AA; 20:4n-6; Figure 3A), linoleic acid (18:2n-6), docosahex-
aenoic acid (DHA; 22:6n-3) and a-linoleic acid (18:3n-3), showed
an elevated trend at Visit 1 and Visit 2. The PUFAs are released
from cell-membrane phospholipids by various phospholipase
enzymes, predominantly phospholipase A2, which is elevated in
dengue patients [29]. Similarly, ten acylcarnitines, two sphingo-
lipids (glucosylceramide and SM), two MG, one DG, one steroid
hormone (cortisol), two purine nucleosides (hypoxanthine and
inosine), one bile pigment (biliverdin), two conjugated bile acids
(glycoursodeoxycholic acid and glycocholic acid), and glucose
showed an increasing trend at Visit 1 and Visit 2 (Figure 3B–3F).
Conversely, a total of twenty PCs, LPCs and lysoPEs showed a
decreased trend (Figure 3G). Ten amino acids and derivatives,
including tryptophan (Figure 3H), glutamic acid etc, also
displayed a downward trend, with the exception of phenylalanine
(Figure 3I), pyroglutamic acid, L-leucyl-L-proline, which showed
an upward trend. The changes of amino acids observed are
consistent with a previous report that described an overall decrease
in plasma amino acid levels in dengue patients, with the exception
of increased phenylalanine in the acute phase of DF patients [30].
We used two well-known pathway analysis tools- MetaboAna-
lyst and IPA, to determine if the metabolites identified here
revealed underlying biochemical pathways. Both these tools
provided similar results, revealing that disturbed metabolic
pathways included fatty acid biosynthesis, fatty acid b-oxidation,
phospholipid catabolism, arachidonic acid metabolism, sphingo-
lipid metabolism, tryptophan metabolism, steroid hormone
biosynthesis, purine metabolism, heme degradation pathway, bile
acid biosynthesis, etc (Figures S4). The Networks function in IPA
indicated that the most significant changes happened with lipid
metabolism and energy production pathways, which is summa-
rized in Figure 4.
Global serum lipid changes with dengue fever
OPLS-DA revealed distinct temporal serum lipidome profiles
with DENV infection (Figure 5A). To understand the lipids and
blood chemistry parameters responsible for the differentiation of
the three visits in the OPLS scores plot, the VIP plot was
generated (Figure 5B). Lymphocyte numbers, SMs, PCs and
lysoPEs influenced the model most significantly. We noted strong
negative correlation between total SM with lymphocyte percent-
age (Pearson r2=0.631, 95% C.I. =20.8848 to 20.6467,
p,0.0001; Figures 6A, S5A). The downward trend of SM
levels across the visits (repeated measures 1-way ANOVA,
p,0.0001) was dominated by SM d18:1/16:0 (m/z
703.7R184.1) which represented ,1/3 of total SM and
exhibited a 5-fold decrease from Visit 1 to 2 (Figure 6B). In
cytotoxic T lymphocytes, acid sphingomyelinase, the enzyme that
hydrolyzes SM to Cer, is a critical factor in the secretory granule-
mediated cell death of virus infected cells [31]. Concordant with
SM hydrolysis to ceramides [32], we observed increased ceramide
levels paralleling the attenuation of SM (Figure S5B). Unlike the
more biologically inert SMs, Cers are potent apoptosis-inducers,
and their glycosylated forms, MHexCers or phosphorylated
forms, C1Ps are bioactive sphingolipids [33]. The initial low Cer
levels were not due to its glycosylation or phosphorylation which
remained low (Figures S5C, S5D), but plausibly compartmen-
tized as the less bioactive SM during the early onset of DF. This is
evidenced by the relatively high SMs levels in the febrile phase
compared to the later defervescence and convalescence phases
(Figure 6C). The development of DENV-specific CD4+ and
CD8+ T-lymphocyte responses [34], and the activation and
contraction of antiviral CD8+ T lymphocytes in the deferves-
cence and convalescence phases of dengue fever has previously
been documented [35]. Therefore, the decrease in SM and
increase in Cer correlated well with the action of T lymphocyte
sphingomyelinase on SM and Cer levels in generating cytotoxic
granules [31].
In our study cohort, MHexCers significantly increased from
Visit 1 to Visit 3 (repeated measures 1-way ANOVA, p,0.01;
Figure S5C), verifying our untargeted metabolomics results.
Conversely, the higher glycosphingolipid, LacCer did not show
significant differences across the visits (Figure S5E).
In our study we found many lysoPEs and pPEs closely
correlated to platelet numbers (Pearson r2 = 0.263–0.4,
p,0.0001; Figures 6C, S6A). By contrast, PEs did not correlate
with platelet numbers (Pearson r2 = 0.0404, 95% C.I. =20.4760
to 0.1096, p=0.217). In addition, their temporal trends differed
from pPEs and lysoPEs (Figures S5B–D). These pPEs are
polyunsaturated and long-chained lipids (34p:2, 36p:4, 38p:4;
38p:5, 38p:6 and 40p:6. Plasmalogen glycerophospholipids are
characterized by vinyl ether bonds at sn-1 position of the glycerol
backbone, and two predominant glycerophospholipids are PEs
and PCs. We also found that LPEs and pPEs strongly correlated
to white blood cell count (Pearson r2 = 0.425, p,0.0001). pPEs
with no or single double bonds and of chain lengths more than
40 carbons correlated poorly, suggesting apparent alkyl chain
length specificity to white blood cell count. Furthermore,
univariate 1-way ANOVA showed that lysoPEs are significantly
increased between Visits 2 and 3 (p,0.0001), and to a lesser
degree between Visits 1 and 2 (p,0.05; Figure S5B). Taken
together, our combined lipidome and blood chemistry analyses
revealed that SMs are associated with early host response
whereas lysoPEs are more associated with late recovery
responses.
Figure 1. PCA (A) and OPLS-DA (B) score plots of dengue fever based onmetabolomics data. The principle component analysis (PCA) and
orthogonal partial least-squares discriminant analysis (OPLS-DA) models were constructed using LC-MS/MS metabolomics data from healthy subjects
and dengue patients at three Visits.
doi:10.1371/journal.pntd.0002373.g001
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Figure 2. Heat map of identified differential metabolites from both LC-MS/MS and GC-MS analyses. Each row shows ion intensity for a
specific metabolite after mean centering and unit variance scaling of the data. Each column shows the serum metabolic profiles of healthy subjects
and dengue patients at three visits. * differential metabolites from GC-MS analysis.
doi:10.1371/journal.pntd.0002373.g002
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Discussion
DF is a self-limiting febrile illness and in most DF cases, there is
complete recovery with little to no manifestations of chronic negative
clinical consequences, clearly indicating human-adapted protective
mechanisms against DENV in DF patients. The protective mecha-
nisms are complex and unfortunately, poorly studied, in part due to
the focus on heterotypic infection and DHF/DSS. The study of the
recovery of DF from a physiologic perspective is therefore important
in advancing our understanding how humans mount a defense and
Figure 3. Typical change trends based on differential metabolite classes. A. elevated change trend of arachidonic acid (free fatty acid). B.
elevated change trend of hexanoylcarnitine (acylcarnitine). C. elevated change trend of glucosylceramide (sphingolipid). D. elevated change trend of
cortisol (steroid hormone). E. elevated change trend of inosine (purine). F. elevated change trend of biliverdine (bile pigment). G. decreased change
trend of PC 38:8 (phospholipid). H. decreased change trend of tryptophan (amino acid). I. elevated change trend of phenylalanine. Median-horizontal
line in the box, The bottom and the top of the box are the 25th and the 75th percentiles, and the black band near the middle of the box is the median
peak area of the metabolite. * p,0.05, ** p,0.01, *** p,0.001, ns, non-significant by test Kruskal-Wallis test. The statistical comparison was with
control levels.
doi:10.1371/journal.pntd.0002373.g003
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recover from DENV infection and potentially other flaviviruses-
induced illnesses. Our current integrated metabolomics and
lipidomics study provides an extensive map of physiologic changes
in adult DF patients, through which we have identified altered
metabolic pathways linked to DENV infection. The relatively large
population size (44 patients and 50 healthy controls) with repeated
sampling at multiple time-points of infection, including early febrile,
defervescence and convalescence stages, captured dynamic changes
in metabolites and the discovery of reliable differential metabolites
that were closely associated with dengue pathophysiology. By using
both LC-MS/MS and GC-MS, we found that approximately 200
serum metabolites were significantly changed, of which 60 were
identified. Lipids, which form a biochemically important subclass of
metabolites, were also independently verified and studied. These
metabolites constituted a mix of pro- as well as anti-inflammatory
mediators, suggesting the rapid host resolution to limit excessive
inflammation and curtail further exacerbation of DENV infection.
Furthermore, these metabolites showed reversible trend changes,
indicating that they might be able to potentially serve as the basis to
develop prognostic markers of the disease.
Infection of humans with DENV causes early pronounced
immunological reactions that shift towards pro-inflammatory
responses [36]. While acute inflammatory response is necessary
in initiating pathogen killing, activation of anti-inflammatory and
pro-resolution processes is important to prevent excessive patho-
logical inflammatory damage to the host. Omega-6 PUFAs, which
Figure 4. Major altered lipid and energy metabolic pathways in dengue patients. The four points on each line represent the levels of each
metabolite at control, Visit 1, Visit 2 and Visit 3, respectively. Differential metabolites colored in red or green represent elevated or decreased change
trend at acute stages (within 1 week) after dengue virus infection compared with healthy control subjects. These changes are reversible and there is
no significant difference for most of the differential metabolites between healthy controls and dengue patients at convalescence stage (week 3–4).
Black-colored metabolites either indicate similar level in healthy controls and dengue fever patients or are undetectable in this study. PC,
phosphatidylcholine; PUFA, polyunsaturated fatty acid; LPC, lysophosphatidylcholine; MG, monoacylglyceride; DG, diacylglyceride; TG,
triacylglyceride; SM, sphingomyelin.
doi:10.1371/journal.pntd.0002373.g004
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are released from cell-membrane phospholipids by phospholipid
hydrolysis, including AA and AA-derived mediators such as
prostaglandins, thromboxanes, hydroxyeicosatetraenoic acids and
leukotrienes (collectively known as eicosanoids) are potent
mediators of inflammation and are involved in modulating both
the intensity and duration of inflammatory responses [37,38].
Contrary to the effects of AA, omega-3 PUFAs, e.g. DHA are
known for their anti-inflammatory activity [39]. Our results
showed an elevated trend of pro- and anti-inflammatory PUFAs
during the febrile stage of DENV infection, including both AA and
DHA, as are total hydroxyeicosatetraenoic acids [40]. Such effects
of active resolution, where AA-associated inflammation incited
early during DENV infection is concomitantly resolved by DHA-
derived anti-inflammatory mediators, and the suppressed produc-
tion of pro-inflammatory cytokines [39], is believed to embrace the
current model of inflammation whereby the return to homeostasis
is an active process, as opposed to a passive one [41]. We also
found increased levels of cortisol, a major, cytokine-activated
glucocorticoid of potent anti-inflammatory and immunosuppres-
sive properties in the febrile stage of DF. Viral infections are
capable of inducing an increase of cortisol in serum during DENV
infection, it had been reported that cortisol level at early febrile
stage was significantly higher than its level at convalescent stage
[42], consistent with our results. The functional role of cortisol in
restraining inflammatory and immune responses by inhibiting the
production of cytokines and other pro-inflammatory mediators
[43] could possibly down-regulate immune responses and protect
the DF patients against cytokine-mediated pathologies. Consistent
Figure 5. Serum lipids and blood chemistry describes distinct time points in primary dengue infection. A. Orthogonal partial least-
squares discriminant analysis (OPLS-DA) models of median-centred and standard deviation scaled glycerophospholipids and sphingolipids and blood
chemistry parameters collected from Visit 1 (1 to 3 days after the onset of fever; febrile phase), Visit 2 (4 to 7 days post fever onset; defervescence
phase) and Visit 3 (21 to 27 days post fever onset; convalescence phase). B. OPLS-DA VIP plot showing the association of serum glycerophospholipids
and sphingolipids with the blood chemistry parameters. Only parameters of VIP values .1.5 are shown. LYMPH#x10‘3/uL, lymphocyte numbers;
LYMPH %, percentage of lymphocytes.
doi:10.1371/journal.pntd.0002373.g005
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with elevated oxidative stress in adult DF patients [44] and
elevated inosine concentrations in the extracellular space at times
of inflammation [45], we found an increased serum inosine in the
febrile phase. Inosine, potentially formed through nitrosative
deamination of adenosine, has been shown to exert wide-ranging
anti-inflammatory effects both in vivo and in vitro, such as inhibition
of pro-inflammatory cytokine/chemokine production and the
enhancement of anti-inflammatory cytokine IL-10 production
[46]. Taken together, our metabolomics results reveal a dynamic
metabolite flux in dengue where an acute inflammation is limited
by swift, dampening responses to restore homeostasis.
In parallel, host immunity has interested dengue investigators in
exploring the mechanisms in the immune system underlying DF
pathogenesis. In primary infections, neutralizing antibody re-
sponses develop after DENV infection and provide persistent
protection against the same serotype even in repeated infections;
even though this may lead to the enhancement of disease severity
upon challenges of a following heterotypic DENV infection.
Increasing evidence demonstrate that self-antigenic glyceropho-
spholipids or glycosphingolipids activate the innate immune
system, noticeably NKT cells in microbial infections [47–50].
Two MHexCers, GlcCer and GalCer, ceramides with b-linked
glucose and a-linked galactose, produced by sphingolipid biosyn-
thesis, have been implicated in invariant natural killer T-cell
(iNKT) activation during microbial infections [47,49,50], and also
NKT cells, which have been implicated in DENV clearance in DF
patients [51,52]. Consistent with this, we found increased GlcCer
levels with the visits and followed the same trend as lymphocyte
numbers. Other immune cells such as dendritic cells, CD4+ and
CD8+ lymphocytes play major roles in viral clearance and as
targets of DENV infection. On the basis of the aforementioned
observations, we postulated that the relationship between SM, Cer
concentrations and immune cells describe multiple early, molec-
ular roles of sphingolipids in mediating the host interactions during
DF. Central among the sphingolipid enzymes is acid sphingomy-
elinase, which has been implicated in numerous immune responses
including, T lymphocyte activation and positive infection by ebola
viruses [53], entry of measles viruses into dendritic cells [54] and
exocytosis of cytolytic granules by T cells [31]. The binding of
extracellular ceramide to the leukocyte mono-immunoglobulin-
like receptor 3 has been recently reported in repressing mast cell
activation [55] and serum ceramides could potentially influence
mast cell surveillance in DENV infection [56]. Likewise, we also
observed the correlation of LPEs and pPEs with white blood cells
and may potentially be related to iNKT activation. Plasmalogen
lysoPEs (pLPE) are self-antigenic and are required for iNKT
stimulation under both physiological conditions and when
challenged with bacteria [48]. We expect that, our findings that
sphingolipids are associated with lymphocytes during DF may
further unravel the significance of T-cell responses and warrants
further investigations. The lack of any significant change in
phosphatidic acids and its lyso form was intriguing given its
Figure 6. Correlation of serum lipids with specific serological parameters. A. Linear correlation of lymphocyte numbers with total
sphingomyelin (SM). B. Quantitative mass spectrometry analysis of individual SM species. C. Scatter plot showing the temporal trend of total SM
during dengue fever. *** P,0.0001. D. Linear correlation of platelet numbers with total lysoPE.
doi:10.1371/journal.pntd.0002373.g006
Metabolomics and Lipidomics of Dengue Fever
PLOS Neglected Tropical Diseases | www.plosntds.org 11 August 2013 | Volume 7 | Issue 8 | e2373
commonly assigned roles in platelet activation. However, it could
be because unlike DHF, DF does not entail severe thrombocyto-
penia and our blood chemistry assays suggest the same.
In the wide spectrum of responses occurring simultaneously with
pathogenic invasions, some metabolic changes may appear to be
general and others more specific. In influenza 2009 pandemic H1N1
infection, extensive changes in serum eicosanoid (e.g. prostaglandin-
F1a, prostaglandin-G, LTA4) and linolenic acid levels were observed
[57]. While linolenic acid is a FFA common to both H1N1 infection
and dengue infection, there was no observable difference in
eicosanoids in DF. Another plausible distinctive metabolome change
in DF compared to H1N1 is the xanthinine derivatives. In 2009
pandemic H1N1 infection, serum methylxanthine levels were lower
during infection relative to after treatment [57]. This result can be
interpreted in two ways: theophylline, a methylxanthine has been
shown to elicit immunomodulator, anti-inflammatory, and bronch-
oprotective properties [58] and such properties may help attenuate
the bronchi damaging effects of 2009 pandemicH1N1 virus as i) part
of the host response [59] or ii) constitute part of the unspecified
treatment. Regardless of which is the reason, methylxanthine points
towards the lung-injury specific consequence of 2009 pandemic
H1N1 infection. On the other hand, in DF, circulating inosine and
hypoxanthine levels increased in the febrile phase where systemic
inflammation may be concerned [60,61]. While studies of increased
inosine and hypoxanthine levels were demonstrated in models of
chronic systemic inflammation, it is conceivable that similar events
could be observed in infectious diseases where acute bouts of
inflammation occur. During inflammation, increased adenosine-to-
inosine editing in cytokine mRNA may interfere with the
degradation of cytokine transcripts and support the early pro-
inflammatory and resolving responses necessary in the early phase of
dengue. This may be reflected in a mixture of pro- and anti-
inflammatory cytokines such as significant IL-4, IL-8 and IFNc
increases in the febrile phase of DF [16].
On the other hand, certain metabolite changes may be more
general across different pathogenic infections. For example, we
found increased phenylalanine levels in the early stages of DF.
Tetrahydrobiopterin (BH4) is a co-factor for phenylalanine (4)-
hydroxylase (PHA), an enzyme required for converting phenylal-
anine to tyrosine, and also NO synthase (NOS) [62]. Through
immune and inflammatory responses-mediated up-regulation of
NOS, NO is elevated during dengue infection [63,64]. Therefore,
NOS competes with PHA for BH4 and this causes an
accumulation of unconverted phenylalanine in the blood. This is
aggravated in the elevated oxidative stress status in DF patients
[44] where superoxide and peroxynitrite increases BH4 oxidation,
thereby depleting the available BH4 pool. Yet, an increased level
of phenylalanine has been commonly observed in other infectious
diseases [65] and given NO’s diverse functions in immunity and
inflammation responses it is not surprising that such changes could
occur in both bacterial and viral infections [66,67]. Another
general effect is energy metabolism. In this study we identified ten
acylcarnitines, which are essential intermediates of fatty acid b-
oxidation (FAO). FAO in liver is suppressed during infection and
inflammation, and increased FFA substrates are then moved away
from oxidation and directed toward re-esterification into TG [68].
The elevated levels of acylcarnitines suggest disturbed FAO in DF
patients, which is in agreement with the observation that the TCA
cycle was affected in an endothelial cell line infected with DENV
[14]. Proteomics and lipidomics work by Diamond et al., showed a
shift in energy metabolism during HCV infection in Huh7.5 cells,
plausibly as a compensatory measure for the energy-demanding
biosynthesis [15]. Similarly, a metabolomics study on severe
pneumonia identified energy metabolism as a perturbed pathway
[10]. Our relatively large number of human samples not only
corrobated the in vitro findings but also showed that energy
metabolism is likely to be a general perturbed pathway in acute
infections. In the absence of large datasets of host-pathogen
‘functional omic’ datasets, we are limited in our ability to make
comparisons and evaluate pathways specific to either bacterial or
viral infections in humans. However, with increasing need to
comprehensively capture the complexity of host-pathogen inter-
actions, and aided by advancements in mass spectrometry and
computational biology [69], we expect more datasets made
available to the community for meaningful comparisons.
The limitations of our study can be discussed in the context of
the host. Firstly, since the current study is restricted to adult
primary infections the findings still need to be expanded and
evaluated in pediatric patients as well as patients with secondary
infections. Secondly, DENV progressively infects a multitude of
cells and organs, including dendritic cells, monocytes, macro-
phages, endothelial cells and liver [70–72]. When we approached
the host response from a systemic perspective, changes of the
chemical composition in the serum could reflect tissue lesions,
organ dysfunctions, pathological states and also compensatory
responses. Thus pinpointing the source or cause of these changes
can be challenging. Nevertheless, our results strongly raise the
implication of distinctive metabolome changes with specific
physiological responses at different phases of dengue infection. It
will require increasing volumes of investigative work to tease apart
the sources of these metabolites, including lipids. More impor-
tantly, as the body of metabolomic work on in vivo viral infections
grows, the potential to derive distinctive and accurate biomarkers
alluding to host responses of various viral infections increases.
In summary, our findings provide a first detailed description of
the metabolome changes in patients with acute dengue infection
and offer a global molecular view that leads to the overall
homeostatic physiological outcome of DF. In addition to providing
host-pathogen insights into the underlying mechanism in symptom
manifestation, metabolites identified in this study might be used
both to monitor disease progression as well as evaluate the efficacy
of therapeutic interventions. Furthermore, certain pathways might
serve as useful therapeutic targets to alleviate severity of dengue.
Such work would be our next endeavour.
Supporting Information
Figure S1 Workflow of serum metabolomics study
based on LC-MS/MS and GC-MS analysis.
(TIF)
Figure S2 Schematic workflow of mass spectrometry-
based lipidomics on serum samples collected from
EDEN study.
(TIF)
Figure S3 Identification of hexanoylcarnitine as a
differential metabolite in dengue fever. A. the extracted
ion chromatogram (EIC) and matched formula of the ion m/z
260.18. B. MS/MS spectrum and proposed fragmentation
pathways of the ion m/z 260.18. C. MS/MS spectrum of a
commercial standard hexanoylcarnitine.
(TIF)
Figure S4 Pathway analysis results by MetaboAnalyst.
(TIF)
Figure S5 Temporal trends of A. lymphocyte numbers
and B. Cer, C. GlcCer, D. C1P and E. LacCer levels.
*p,0.05; **p,0.01.
(TIF)
Metabolomics and Lipidomics of Dengue Fever
PLOS Neglected Tropical Diseases | www.plosntds.org 12 August 2013 | Volume 7 | Issue 8 | e2373
Figure S6 Temporal trends of A. platelet numbers and
B. lysoPE, C. pPE and D. PE levels. *p,0.05; ***p,0.0001.
(TIF)
Figure S7 Scatter plots for the major differential
metabolite classes. A. arachidonic acid B. hexanoylcarnitine
C. glucosylceramide D. cortisol E. inosine F. biliverdine G. PC
38:8 H. tryptophan I. phenylalanine. The black band near the
middle of the plot is the mean peak area of the metabolite.
(TIF)
Table S1 Reproducibility evaluation based on selected
peaks in quality control samples.
(DOCX)
Table S2 Optimized lipid-dependent mass spectrome-
try parameters for MRM.
(XLSX)
Table S3 Linearity, Limit of Detection (LOD) and Limit
of Quantitation (LOQ) of sphingolipids. LOD and LOQ
were determined according to the International Confer-
ence on Harmonization (ICH) guidelines.
(XLSX)
Table S4 Identified differential metabolites from LC-
MS/MS analysis.
(DOCX)
Table S5 Unidentified differential metabolites from
LC-MS/MS analysis.
(DOCX)
Author Contributions
Conceived and designed the experiments: LC YHL YK EEO SRT CNO.
Performed the experiments: LC YHL. Analyzed the data: LC YHL YK
FX KL. Contributed reagents/materials/analysis tools: LC YHL YK FX
KL EEO SRT CNO. Wrote the paper: LC YHL YK EEO SRT CNO.
References
1. Halstead SB, Suaya JA, Shepard DS (2007) The burden of dengue infection.
Lancet 369: 1410–1411.
2. Gubler DJ (2002) The global emergence/resurgence of arboviral diseases as
public health problems. Arch Med Res 33: 330–342.
3. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, et al. (2010) Dengue: a
continuing global threat. Nat Rev Microbiol 8: S7–16.
4. Gubler DJ (1998) Dengue and dengue hemorrhagic fever. Clin Microbiol Rev
11: 480–496.
5. Nicholson JK, Lindon JC, Holmes E (1999) ‘Metabonomics’: understanding the
metabolic responses of living systems to pathophysiological stimuli via
multivariate statistical analysis of biological NMR spectroscopic data. Xenobio-
tica 29: 1181–1189.
6. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, et al. (2009)
Metabolomic profiles delineate potential role for sarcosine in prostate cancer
progression. Nature 457: 910–914.
7. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, et al. (2011) Gut flora
metabolism of phosphatidylcholine promotes cardiovascular disease. Nature
472: 57–63.
8. Vinayavekhin N, Homan EA, A S (2010) Exploring disease through
metabolomics. ACS Chem Biol 15: 91–103.
9. Al-Mubarak R, Vander Heiden J, Broeckling CD, Balagon M, Brennan PJ, et al.
(2011) Serum metabolomics reveals higher levels of polyunsaturated fatty acids
in lepromatous leprosy: potential markers for susceptibility and pathogenesis.
PLoS Negl Trop Dis 5: e1303.
10. Laiakis EC, Morris GA, Fornace AJ, Howie SR (2010) Metabolomic analysis in
severe childhood pneumonia in the Gambia, West Africa: findings from a pilot
study. PLoS One 5: e12655.
11. Heaton NS, Perera R, Berger KL, Khadka S, Lacount DJ, et al. (2010) Dengue
virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral
replication and increases cellular fatty acid synthesis. Proc Natl Acad Sci U S A
107: 17345–17350.
12. Rothwell C, Lebreton A, Young Ng C, Lim JY, Liu W, et al. (2009) Cholesterol
biosynthesis modulation regulates dengue viral replication. Virology 389: 8–19.
13. Zaitseva E, Yang ST, Melikov K, Pourmal S, Chernomordik LV (2010) Dengue
virus ensures its fusion in late endosomes using compartment-specific lipids.
PLoS Pathog 6: e1001131.
14. Birungi G, Chen SM, Loy BP, Ng ML, Li SF (2010) Metabolomics approach for
investigation of effects of dengue virus infection using the EA.hy926 cell line.
J Proteome Res 9: 6523–6534.
15. Diamond DL, Syder AJ, Jacobs JM, Sorensen CM, Walters KA, et al. (2010)
Temporal proteome and lipidome profiles reveal hepatitis C virus-associated
reprogramming of hepatocellular metabolism and bioenergetics. PLoS Pathog 6:
e1000719.
16. Kumar Y, Liang C, Bo Z, Rajapakse JC, Ooi EE, et al. (2012) Serum Proteome
and Cytokine Analysis in a Longitudinal Cohort of Adults with Primary Dengue
Infection Reveals Predictive Markers of DHF. PLoS Negl Trop Dis 6: e1887.
17. Low JG, Ooi EE, Tolfvenstam T, Leo YS, Hibberd ML, et al. (2006) Early
Dengue infection and outcome study (EDEN) - study design and preliminary
findings. Ann Acad Med Singapore 35: 783–789.
18. Low JG, Ong A, Tan LK, Chaterji S, Chow A, et al. (2011) The early clinical
features of dengue in adults: challenges for early clinical diagnosis. PLoS Negl
Trop Dis 5: e1191.
19. WHO (1997) Dengue Hemorrhagic Fever: diagnosis, treatment, prevention, and
control. Geneva: World Health Organization.
20. Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and
purification. Can J Biochem Physiol 37: 911–917.
21. Ng DP, Salim A, Liu Y, Zou L, Xu FG, et al. (2012) A metabolomic study of low
estimated GFR in non-proteinuric type 2 diabetes mellitus. Diabetologia 55:
499–508.
22. Han X, Gross RW (2005) Shotgun lipidomics: electrospray ionization mass
spectrometric analysis and quantitation of cellular lipidomes directly from crude
extracts of biological samples. Mass Spectrom Rev 24: 367–412.
23. Shaner RL, Allegood JC, Park H, Wang E, Kelly S, et al. (2009) Quantitative
analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole
linear ion trap mass spectrometers. J Lipid Res 50: 1692–1707.
24. Brugger B, Erben G, Sandhoff R, Wieland FT, Lehmann WD (1997)
Quantitative analysis of biological membrane lipids at the low picomole level
by nano-electrospray ionization tandem mass spectrometry. Proc Natl Acad
Sci U S A 94: 2339–2344.
25. Pluskal T, Castillo S, Villar-Briones A, Oresic M (2010) MZmine 2: modular
framework for processing, visualizing, and analyzing mass spectrometry-based
molecular profile data. BMC Bioinformatics 11: 395.
26. Chen J, Zhao X, Fritsche J, Yin P, Schmitt-Kopplin P, et al. (2008) Practical
approach for the identification and isomer elucidation of biomarkers detected in
a metabonomic study for the discovery of individuals at risk for diabetes by
integrating the chromatographic and mass spectrometric information. Anal
Chem 80: 1280–1289.
27. Zuniga A, Li L (2011) Ultra-high performance liquid chromatography tandem
mass spectrometry for comprehensive analysis of urinary acylcarnitines. Anal
Chim Acta 689: 77–84.
28. Xia J, Psychogios N, Young N, Wishart DS (2009) MetaboAnalyst: a web server
for metabolomic data analysis and interpretation. Nucleic Acids Res 37: W652–
660.
29. Nevalainen TJ, Losacker W (1997) Serum phospholipase A2 in dengue. J Infect
35: 251–252.
30. Klassen P, Furst P, Schulz C, Mazariegos M, Solomons NW (2001) Plasma free
amino acid concentrations in healthy Guatemalan adults and in patients with
classic dengue. Am J Clin Nutr 73: 647–652.
31. Herz J, Pardo J, Kashkar H, Schramm M, Kuzmenkina E, et al. (2009) Acid
sphingomyelinase is a key regulator of cytotoxic granule secretion by primary T
lymphocytes. Nat Immunol 10: 761–768.
32. Nixon GF (2009) Sphingolipids in inflammation: pathological implications and
potential therapeutic targets. Br J Pharmacol 158: 982–993.
33. Hannun YA, Luberto (2000) Ceramide in the eukaryotic stress response. Trends
Cell Biol 10: 73–80.
34. Gagnon SJ, Zeng W, Kurane I, Ennis FA (1996) Identification of two epitopes
on the dengue 4 virus capsid protein recognized by a serotype-specific and a
panel of serotype-cross-reactive human CD4+ cytotoxic T-lymphocyte clones.
J Virol 70: 141–147.
35. Sandalova E, Laccabue D, Boni C, Tan AT, Fink K, et al. (2010) Contribution
of herpesvirus specific CD8 T cells to anti-viral T cell response in humans. PLoS
Pathog 6: e1001051.
36. Mathew A, Rothman AL (2008) Understanding the contribution of cellular
immunity to dengue disease pathogenesis. Immunol Rev 225: 300–313.
37. Lewis RA, Austen KF, Soberman RJ (1990) Leukotrienes and other products of
the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in
human diseases. N Engl J Med 323: 645–655.
38. Serhan CN (2011) The resolution of inflammation: the devil in the flask and in
the details. Faseb J 25: 1441–1448.
39. Calder PC (2001) Polyunsaturated fatty acids, inflammation, and immunity.
Lipids 36: 1007–1024.
Metabolomics and Lipidomics of Dengue Fever
PLOS Neglected Tropical Diseases | www.plosntds.org 13 August 2013 | Volume 7 | Issue 8 | e2373
40. Seet RC, Lee CY, Lim EC, Quek AM, Yeo LL, et al. (2009) Oxidative damage
in dengue fever. Free Radic Biol Med 47: 375–380.
41. Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, et al. (2007)
Resolution of inflammation: state of the art, definitions and terms. Faseb J 21:
325–332.
42. Myo K, Soe T, Thein Thein M, Than Nu S, Tin Tin S, et al. (1995) Serum
cortisol levels in children with dengue haemorrhagic fever. J Trop Pediatr 41:
295–297.
43. Ruzek MC, Pearce BD, Miller AH, Biron CA (1999) Endogenous glucocorti-
coids protect against cytokine-mediated lethality during viral infection.
J Immunol 162: 3527–3533.
44. Gil L, Martinez G, Tapanes R, Castro O, Gonzalez D, et al. (2004) Oxidative
stress in adult dengue patients. Am J Trop Med Hyg 71: 652–657.
45. Hellewell PG, Pearson JD (1983) Metabolism of circulating adenosine by the
porcine isolated perfused lung. Circ Res 53: 1–7.
46. Hasko G, Kuhel DG, Nemeth ZH, Mabley JG, Stachlewitz RF, et al. (2000)
Inosine inhibits inflammatory cytokine production by a posttranscriptional
mechanism and protects against endotoxin-induced shock. J Immunol 164:
1013–1019.
47. Brennan PJ, Tatituri RV, Brigl M, Kim EY, Tuli A, et al. (2011) Invariant
natural killer T cells recognize lipid self antigen induced by microbial danger
signals. Nat Immunol 12: 1202–1211.
48. Facciotti F, Ramanjaneyulu GS, Lepore M, Sansano S, Cavallari M, et al.
(2012) Peroxisome-derived lipids are self antigens that stimulate invariant natural
killer T cells in the thymus. Nat Immunol 13: 474–480.
49. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, et al. (1997) CD1d-restricted
and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.
Science 278: 1626–1629.
50. Mattner J, Debord KL, Ismail N, Goff RD, Cantu C, 3rd, et al. (2005)
Exogenous and endogenous glycolipid antigens activate NKT cells during
microbial infections. Nature 434: 525–529.
51. Azeredo EL, De Oliveira-Pinto LM, Zagne SM, Cerqueira DI, Nogueira RM, et
al. (2006) NK cells, displaying early activation, cytotoxicity and adhesion
molecules, are associated with mild dengue disease. Clin Exp Immunol 143:
345–356.
52. Zigmond E, Preston S, Pappo O, Lalazar G, Margalit M, et al. (2007) Beta-
glucosylceramide: a novel method for enhancement of natural killer T
lymphoycte plasticity in murine models of immune-mediated disorders. Gut
56: 82–89.
53. Miller ME, Adhikary S, Kolokoltsov AA, Davey RA (2012) Ebolavirus requires
acid sphingomyelinase activity and plasma membrane sphingomyelin for
infection. J Virol 86: 7473–7483.
54. Avota E, Gulbins E, Schneider-Schaulies S (2011) DC-SIGN mediated
sphingomyelinase-activation and ceramide generation is essential for enhance-
ment of viral uptake in dendritic cells. PLoS Pathog 7: e1001290.
55. Izawa K, Yamanishi Y, Maehara A, Takahashi M, Isobe M, et al. (2012) The
Receptor LMIR3 Negatively Regulates Mast Cell Activation and Allergic
Responses by Binding to Extracellular Ceramide. Immunity 37: 827–839.
56. St John AL, Rathore AP, Yap H, Ng ML, Metcalfe DD, et al. (2011) Immune
surveillance by mast cells during dengue infection promotes natural killer (NK)
and NKT-cell recruitment and viral clearance. Proc Natl Acad Sci U S A 108:
9190–9195.
57. Lu C, Jiang Z, Fan X, Liao G, Li S, et al. (2012) A metabonomic approach to
the effect evaluation of treatment in patients infected with influenza A (H1N1).
Talanta 15;100:51–56.
58. Tilley SL (2011) Methylxanthines in asthma. Handb Exp Pharmacol 200:439–
456.
59. Guarner J, Falco´n-Escobedo R (2009) Comparison of the pathology caused by
H1N1, H5N1, and H3N2 influenza viruses. Arch Med Res 40:655–661.
60. Yang JH, Luo X, Nie Y, Su Y, Zhao Q, (2003) Widespread inosine-containing
mRNA in lymphocytes regulated by ADAR1 in response to inflammation.
Immunology 109:15–23.
61. Mangerich A, Knutson CG, Parry NM, Muthupalani S, Ye W, et al. (2012)
Infection -induced colitis in mice causes dynamic and tissue-specific changes in
stress response and DNA damage leading to colon cancer. Proc Natl Acad Sci
USA 109: E1820–1829.
62. Shi W, Meininger CJ, Haynes TE, Hatakeyama K, Wu G (2004) Regulation of
tetrahydrobiopterin synthesis and bioavailability in endothelial cells. Cell
Biochem Biophys 41: 415–434.
63. Neves-Souza PC, Azeredo EL, Zagne SM, Valls-de-Souza R, Reis SR, et al.
(2005) Inducible nitric oxide synthase (iNOS) expression in monocytes during
acute Dengue Fever in patients and during in vitro infection. BMC Infect Dis 5:
64.
64. Takhampunya R, Padmanabhan R, Ubol S (2006) Antiviral action of nitric
oxide on dengue virus type 2 replication. J Gen Virol 87: 3003–3011.
65. Wannemacher RW, Jr., Klainer AS, Dinterman RE, Beisel WR (1976) The
significance and mechanism of an increased serum phenylalanine-tyrosine ratio
during infection. Am J Clin Nutr 29: 997–1006.
66. Nathan CF, Hibbs JB, Jr. (1991) Role of nitric oxide synthesis in macrophage
antimicrobial activity. Curr Opin Immunol 3: 65–70.
67. Akaike T, Maeda H (2000) Nitric oxide and virus infection. Immunology 101:
300–308.
68. Suvarna JC, Rane PP (2009) Serum lipid profile: a predictor of clinical outcome
in dengue infection. Trop Med Int Health 14: 576–585.
69. Goh WW, Lee YH, Chung M, Wong L (2012) How advancement in biological
network analysis methods empowers proteomics. Proteomics 12: 550–563.
70. Jessie K, Fong MY, Devi S, Lam SK, Wong KT (2004) Localization of dengue
virus in naturally infected human tissues, by immunohistochemistry and in situ
hybridization. J Infect Dis 189: 1411–1418.
71. Noisakran S, Onlamoon N, Songprakhon P, Hsiao HM, Chokephaibulkit K, et
al. (2010) Cells in dengue virus infection in vivo. Adv Virol 2010: 164878.
72. Murphy BR, Whitehead SS (2011) Immune response to dengue virus and
prospects for a vaccine. Annu Rev Immunol 29: 587–619.
Metabolomics and Lipidomics of Dengue Fever
PLOS Neglected Tropical Diseases | www.plosntds.org 14 August 2013 | Volume 7 | Issue 8 | e2373
